Detailed Information

Cited 0 time in webofscience Cited 1 time in scopus
Metadata Downloads

Prolonged loss of intercostal muscle mass and its predictors in COVID-19 patients: A retrospective study from tertiary hospitalopen access

Authors
Koo, Byeong JuChoi, Ho CheolChoi, Hye YoungShin, Hwa SeonWon, Jung HoHong, Seok JinYang, Won JeongAhn, Jae KyeongPark, Mi Jung
Issue Date
May-2024
Publisher
Lippincott Williams & Wilkins Ltd.
Keywords
COVID-19; sarcopenia; thoracic wall
Citation
Medicine, v.103, no.22, pp E38284
Indexed
SCIE
SCOPUS
Journal Title
Medicine
Volume
103
Number
22
Start Page
E38284
URI
https://scholarworks.gnu.ac.kr/handle/sw.gnu/70855
DOI
10.1097/MD.0000000000038284
ISSN
0025-7974
1536-5964
Abstract
Sarcopenia is a contributing factor in the development of long-COVID syndrome. We aimed to investigate how intercostal muscle mass changes over 3 months compared to other chest wall muscles following COVID-19 infection, along with identifying factors contributing to intercostal muscle loss during follow-up. We retrospectively studied 110 COVID-19 patients, analyzing muscle masses in the intercostal, pectoralis, and thoracic 12th vertebra level (T12) on initial and follow-up CT scans. Muscle mass was quantitatively assessed using density histogram analysis. We calculated the muscle difference ratio (MDR) as the following formula: (initial muscle mass - follow-up muscle mass)/initial muscle mass. Patients were categorized into 2 groups: <3 months follow-up (n = 53) and >= 3 months follow-up (n = 57). We employed stepwise logistic regression, using intercostal MDR >= 25% in follow-up as an independent variable and age < 65 years, ventilator use, steroid use, follow-up > 3 months, hospital stay > 13 days, body mass index < 18.5 kg/m(2), and female gender as dependent variables. The loss of intercostal muscle was the most severe among the 3 chest wall muscles in the CT follow-up. Intercostal MDR was significantly higher in the >= 3 months follow-up group compared to the < 3 months group (32.5 +/- 23.6% vs 19.0 +/- 21.1%, P = .002). There were no significant differences in pectoralis MDR or T12 MDR between the 2 groups. Stepwise logistic regression identified steroid use (3.494 (1.419-8.604), P = .007) and a follow-up period > 3 months [3.006 (1.339-6.748), P = .008] as predictors of intercostal MDR >= 25%. The intercostal muscle wasting was profound compared to that in the pectoralis and T12 skeletal muscles in a follow-up CT scan, and the intercostal muscle wasting was further aggravated after 3 months of COVID-19 infection. The use of steroids and a follow-up period exceeding 3 months were significant predictors for >= 25% of intercostal muscle wasting in follow-up.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medicine > Journal Articles
의학계열 > 의학과 > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Choi, Hye Young photo

Choi, Hye Young
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE